Ubs Asset Management Americas Inc 89bio, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 178,691 shares of ETNB stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178,691
Previous 140,998
26.73%
Holding current value
$1.89 Million
Previous $1.04 Million
31.35%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ETNB
# of Institutions
175Shares Held
125MCall Options Held
84KPut Options Held
941K-
Janus Henderson Group PLC London, X016.5MShares$175 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$150 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$108 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$79 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$74.2 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $491M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...